A brain proteomic signature of incipient Alzheimer's disease in young APOE e4 carriers identifies novel drug targets.
A brain proteomic signature of incipient Alzheimer's disease in young APOE e4 carriers identifies novel drug targets. Sci Adv. 2021 Nov 12; 7(46):eabi8178.